Oxford Genetics

About:

Oxford Genetics is a biotechnology company producing versatile cloning plasmids for research.

Top Investors: Innovate UK, Mercia Fund Managers, Mercia Asset Management, Invesco Perpetual

Description:

Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and biotechnology institutions. They also provide custom cloning and DNA synthesis. All of their products are free of intellectual property restrictions.

Total Funding Amount:

16.8M GBP

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Upper Heyford, Somerset, United Kingdom

Founded Date:

2011-04-28

Contact Email:

socialmedia(AT)oxgene.co.uk

Founders:

Leonard Seymour, Ryan Cawood

Number of Employees:

51-100

Last Funding Date:

2019-04-03

IPO Status:

Private

Industries: